NLM Digital Collections

Search

Start Over Authors Pearson, Steven D., author ✖Remove constraint Authors: Pearson, Steven D., author Authors Rind, David M., author ✖Remove constraint Authors: Rind, David M., author

11. Valoctocogene roxaparvovec and emicizumab for hemophilia A without inhibitors: effectiveness and value : final report

Author(s):
Rind, David M., author
Walton, Surrey M., author
Agboola, Foluso, author
Herron-Smith, Serina, author
Quach, Danny, author
Chapman, Rick M., author
Pearson, Steven D., author
Bradt, Pamela, author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, November 20, 2020
Subject(s):
Antibodies, Monoclonal
Genetic Therapy
Hemophilia A -- drug therapy
United States

12. Aducanumab for Alzheimer’s disease: effectiveness and value

Author(s):
Lin, Grace A., author
Whittington, Melanie D., author
Synnott, Patricia G., author
McKenna, Avery, author
Campbell, Jon, author
Pearson, Steven D., author
Rind, David M., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, August 5, 2021
Subject(s):
Alzheimer Disease -- drug therapy
Antibodies, Monoclonal
United States

13. Crizanlizumab, voxelotor, and L-glutamine for sickle cell disease: effectiveness and value

Author(s):
Bradt, Pamela, author
Synnott, Patricia G., author
Chapman, Rick, author
Beinfeld, Molly, author
Rind, David M., author
Pearson, Steven D., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, March 12, 2020
Subject(s):
Anemia, Sickle Cell -- drug therapy
Antibodies, Monoclonal -- therapeutic use
Glutamine -- therapeutic use
Hemoglobin, Sickle -- antagonists & inhibitors
United States

15. Treatments for anemia in chronic kidney disease: effectiveness and value : final evidence report

Author(s):
Mustafa, Reem A., author
Fox, Grace, (Of Institute for Clinical and Economic Review), author
Campbell, Jonathan D., author
Agboola, Foluso, author
Pearson, Steven D., author
Rind, David M., author
Bloudek, Lisa, author
Carlson, Josh J., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, March 5, 2021
Subject(s):
Glycine -- analogs & derivatives
Hematinics -- therapeutic use
Isoquinolines -- therapeutic use
Hypoxia-Inducible Factor-Proline Dioxygenases -- antagonists & inhibitors
Anemia, Iron-Deficiency -- drug therapy
Renal Insufficiency, Chronic -- complications
Renal Insufficiency, Chronic -- drug therapy
Treatment Outcome
United States

16. Gene therapies for sickle cell disease: final evidence report

Author(s):
Beaudoin, Francesca, author
Nikitin, Dmitriy, author
Campbell, Jonathan D., author
McKenna, Avery, author
Pearson, Steven D., author
Rind, David M., author
Thokala, P. (Praveen), author
Spackman, David Eldon, author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, August 21, 2023
Subject(s):
Anemia, Sickle Cell -- therapy
Genetic Therapy
United States

17. Resmetirom and obeticholic acid for non-alcoholic steatohepatitis (NASH): final evidence report

Author(s):
Tice, Jeffrey A., author
Fahim, Shahariar Mohammed, author
Richardson, Marina, author
Herce-Hagiwara, Belen, author
Chu, Janet N., author
Pearson, Steven D., author
Rind, David M., author
Suh, Kangho, author
Carlson, Josh, author
Dickerson, Ronald, author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, May 25, 2023
Subject(s):
Chenodeoxycholic Acid -- analogs & derivatives
Liver Cirrhosis -- drug therapy
Non-alcoholic Fatty Liver Disease -- drug therapy
Pyridazines
Uracil -- analogs & derivatives
United States

18. JAK inhibitors and monoclonal antibodies for the treatment of atopic dermatitis: effectiveness and value : final evidence report

Author(s):
Atlas, Steven J., author
Fox, Grace E., author
Agboola, Foluso, author
Campbell, Jonathan D., author
Pearson, Steven D., author
Rind, David M., author
Brouwer, Elizabeth, author
Carlson, Josh, author
Chen, Yilin, (Of University of Washington), author
Hansen, Ryan N., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, February 27, 2023
Subject(s):
Antibodies, Monoclonal -- therapeutic use
Dermatitis, Atopic
Janus Kinase Inhibitors -- therapeutic use
United States

19. Tezepelumab for severe asthma: final report

Author(s):
Rind, David M., author
Campbell, Jonathan D., author
Herce-Hagiwara, Belén, author
Herron-Smith, Serina, author
Fluetsch, Noemi, author
Pearson, Steven D., author
McQueen, R. Brett, author
Gutierrez, Eric, (Of University of Colorado), author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, February 13, 2023
Subject(s):
Antibodies, Monoclonal, Humanized -- therapeutic use
Asthma -- drug therapy
United States

20. Fezolinetant for moderate to severe vasomotor symptoms associated with menopause: effectiveness and value : final evidence report

Author(s):
Beaudoin, Francesca L., author
Wright, Abigail, (Of Institute for Clinical and Economic Review), author
Yeung, Kai, 1981- author
Moradi, Ashton, author
Herron-Smith, Serina, author
Pearson, Steven D., author
Rind, David M., author
Lin, Grace A., author
McQueen, R. Brett, author
Gutierrez, Eric, (Of School of Pharmacy, University of Colorado), author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, January 23, 2023
Subject(s):
Cost-Effectiveness Analysis
Heterocyclic Compounds, 2-Ring
Hot Flashes
Menopause
Thiadiazoles
Vasomotor System
United States